Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 555  

  Article Access Statistics

Year : 2021 | Volume:  20 | Issue Number:  3 | Page:  316-318

CASE REPORT

Everolimus-induced somatostatin receptor overexpression in a rectal neuroendocrine tumor patient may promote somatostatin receptor-guided radionuclide therapy (peptide receptor radiotherapy) as an additional treatment option
Mileva Magdalena, Wimana Zéna, Flamen Patrick, Karfis Ioannis

Number of times this article was viewed 406
Number of times this article has been printed  from the site 44
Number of times this article was emailed to others 0
Remarks given by readers [ Read ] 0

 

  Feedback 
  Subscribe 
 Back To Article

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal